
This webinar has passed.
When?
Start:
November 16, 2023
12:00 PM
End:
November 16, 2023
1:00 PM

Please, Give Me a Vendor Database That Works! Biopharmaceutical companies and the CROs have been struggling with achieving greater visibility in their clinical vendor portfolios and the challenges are only getting bigger, impacting compliance to vendor oversight regulations and heightening vendor portfolio risks. The intense M&A and rebranding activity in the clinical marketplace, the emergence of new e-clinical service categories and the shrinking of the dedicated vendor management resource pool have further compounded the pain points, and the need for sustainable solutions. In the age of tech-enabled procurement, the time has come to replace the notorious Excel “vendor tracker” with a central hub for vendor performance management and bring visibility and oversight compliance to clinical trial management.
Strengthen your processes and increase data-driven decision-making for faster study start-ups.

This webinar has passed.
When?
Start:
November 16, 2023
12:00 PM
End:
November 16, 2023
1:00 PM
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence

Webinars
Technology for Fast, Accurate Planning and Budgeting
Leading biopharmaceutical sponsors trust PORTFOLIO for pipeline planning and budgeting with superior results and reported more than 10x Return on Investment.

Blogs
Driving Customer Success Through Governance: Transforming Pharma Vendor Management with AI Innovation
Effective vendor governance is essential to ensure operational success, cost efficiency, and regulatory compliance.

Case Studies
Streamlining Vendor Management: How a Leading Biopharma Company Found Success
DEMO
Request a demo
Discover how Strategikon’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.